Clinical Trials in Philadelphia

Showing 15041-15060 of 20,904 trials

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

NCT00726323

This clinical study is being conducted at multiple sites to determine the best confirmed response rate, safety, and tolerability of GSK1363089 treatment in papillary renal cell carcinoma. Papillary renal cell carcinoma may be classified into hereditary and sporadic forms; subjects with either classification will be accepted into this study.

Carcinoma, Renal Cell

GlaxoSmithKline74 participantsStarted Jun 2006

Greenbrae, California, United States • San Francisco, California, United States • Stanford, California, United States +9 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation

NCT00910962

This is a randomized, double-blind, placebo-controlled, parallel group, multi-center study to evaluate initial safety and efficacy of GW856553 in subjects with NSTEMI. Up to approximately 525 subjects will be randomized to meet the MRI recruitment target (90 subjects in substudy.) All subjects will continue to receive the local standard of care for the duration of the study.

Acute Coronary Syndrome

GlaxoSmithKline526 participantsStarted Oct 2009

Anchorage, Alaska, United States • Tucson, Arizona, United States • Los Angeles, California, United States +105 more locations

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation

Find Trials by Condition in Philadelphia

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Use of Infliximab for the Treatment of Pemphigus Vulgaris

A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Comparison of Cervical Laminectomy to Laminoplasty

International PFO Consortium

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer